Westlake Village, CA, United States of America

Alexander J Pickrell

This inventor holds 31 USPTO granted patents and 12 published patent applications, plus 3 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Compounds. Top assignee: Amgen Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexander J Pickrell. Retrieved from https://idiyas.com/inventor/alexander-j-pickrell

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 12.4

ph-index = 6

Forward Citations = 167(Granted Patents)


Location History:

  • Thousand Oaks, CA (US) (2020 - 2022)
  • Westlake Village, CA (US) (2009 - 2024)

Company Filing History:


Years Active: 2009-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
KRAS G12C Inhibitors
PDE10 Inhibitors
MCL-1 Protein Inhibitors
Apelin Polypeptides
Spiro Compounds
Cyclopropyl Derivatives
Azetidine Compounds
Naphthalenone Compounds
Carbohydrate Phosphonates
Heteroaryloxycarbocyclyl Compounds
Aminopyridine Compounds
31 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Alexander J Pickrell

Introduction

Meet Alexander J Pickrell, a prolific inventor in the heart of Westlake Village, CA. With an impressive track record of 26 patents to his name, Pickrell is at the forefront of groundbreaking discoveries in the field of biotechnology and pharmaceuticals.

Latest Patents

Pickrell's recent patents showcase his ingenuity and dedication to advancing medical treatments. One notable invention is the development of Apelin polypeptides, which are modified to enhance stability, circulating half-life, and potency. These polypeptides offer promising solutions for treating cardiac disorders, particularly heart failure. Additionally, Pickrell has pioneered KRAS G12C inhibitors, a breakthrough in targeting pancreatic, colorectal, and lung cancers with precision and efficacy.

Career Highlights

Currently employed at Amgen Inc., Pickrell continues to push the boundaries of science and innovation. His contributions have significantly impacted the development of cutting-edge therapies that improve patient outcomes and quality of life. Pickrell's unwavering commitment to research and development underscores his passion for making a difference in the healthcare landscape.

Collaborations

In his pursuit of excellence, Pickrell has collaborated with esteemed professionals in the industry. Notably, his partnerships with Michael J Frohn and Jennifer Rebecca Allen have led to synergistic efforts in driving forward novel ideas and transformative solutions in healthcare. Through collaborative endeavors, Pickrell has cultivated a network of like-minded visionaries dedicated to advancing medical science.

Conclusion

Alexander J Pickrell's inventive spirit and relentless drive have solidified his position as a trailblazer in the realm of medical innovation. With a wealth of patents under his belt and a commitment to pushing the boundaries of possibility, Pickrell embodies the essence of a true visionary shaping the future of healthcare. As he continues to pioneer groundbreaking inventions, the impact of his work reverberates throughout the industry, offering hope and healing to those in need.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…